Ann: Positive PanCO trial update on resected cohort, page-2

So according to OSL release , the survival data are in line with what would be expected with neoadjuvant chemotherapy.
- but in Panco trial these patients received neoadjuvant chemo plus oncosil device
- so isn’t this just saying if results are in line with neoadjuvant chemo as OSL state, the device doesn’t add any further benefit over what you’d expect with chemo??
- they should really present the median survival for all 10
- to me these results are ok, and obviously good for the 6 who’ve made it this far- but overall not stand-out
- why haven’t they provided updated survival for the whole study?